C94.8 - Other specified leukemias
- Applicable to Other specified leukemias
- The 2025 edition of ICD10-CM C94.8 became effective on October 1, 2024.
- This is the American ICD10-CM version of C94.8 - other international versions of ICD10 C94.8 may differ.
- C94.8 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- C94.8 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- C94.8 - Other specified leukemias
- C94.8 - Other specified leukemias
- C94.80 - Other specified leukemias not having achieved remission
- C94.81 - Other specified leukemias, in remission
- C94.82 - Other specified leukemias, in relapse
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Aggressive NK-cell leukemia
- Acute basophilic leukemia
codeAlso
- , if applicable, eosinophilia (D72.18)
Non-Billable/Non-Specific Code
The following codes above C94.8 contain annotation back-references that may be applicable to C94.8:
- Chapter: C00-D49 - Neoplasms
- Section: C81-C96 - Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Category: C94 - Other leukemias of specified cell type
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com